November 21, 2018
1 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Study finds iStent inject safe, efficacious
SAN ANTONIO – Bobby Saenz, OD, MS, FAAO, reported here at the American Academy of Optometry meeting that the iStent inject produced a greater than 20% reduction in diurnal IOP in a randomized, prospective trial.
“We can be confident that we can recommend the iStent inject for our mild to moderate glaucoma patients who are getting cataract surgery due to its safety profile and that it’s really efficacious,” he said.